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Abstract
Background: Plasmodium falciparum malaria is a complex disease in which genetic and environmental factors
influence susceptibility. IgG isotypes are in part genetically controlled, and GM/KM allotypes are believed to be
involved in this control.
Methods: In this study, 216 individuals from Daraweesh, an area of seasonal malaria transmission in Sudan, were
followed for nine years for malaria infection. Total IgG and IgG isotypes against four malaria antigens, MSP2-3D7,
MSP2-FC27, AMA1, and Pf332-C231 were measured in plasma obtained from the cohort at the end of the study,
during the dry malaria-free period. The GM/KM allotypes of the donors were determined.
Results: The GM 1,17 5,13,14,6 phenotype was associated with a higher incidence of malaria compared with the
non-1,17 5,13,14,6 phenotypes (P = 0.037). Paradoxically, the carriers of the GM 1,17 5,13,14,6 phenotype had
significantly higher baseline levels of total IgG and non-cytophilic IgG isotypes as compared to non-carriers. The
KM allotypes influence on IgG isotypes level was limited. Finally, the differences in the baseline concentrations of
total IgG and IgG isotypes between the different GK/KM phenotype carriers were antigen-dependent.
Discussion: The results show that GM but not KM allotypes appeared to influence host susceptibility to
uncomplicated malaria as well as the antibody profile of the donors, and the carriers of the GM 1,17 5,13,14,6
phenotype were the most susceptible
Conclusions: The GM allotypes have significant influence on susceptibility to uncomplicated P. falciparum malaria
and antigen-dependent influence on total IgG and IgG subclasses.
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Background
Selection for resistance to malaria among inhabitants of
malaria endemic regions may have influenced polymor-
phisms in genes encoding a variety of proteins involved in
immunity [1]. For example, different subclasses of immu-
noglobulin G (IgG isotypes) have been proposed to play
opposing roles in protection against malaria [2].
Cytophilic IgG (IgG1 and IgG3) antibodies were shown to
be protective, while non-cytopihlic ones (IgG2 and IgG4)
were found to be competing with the former isotypes
[2,3]. Thus, not only levels, but also switching between
IgG isotypes is believed to play a role in development of
protective immunity. Protein polymorphism within the
individual IgG subclasses is in part due to GM/KM allo-
types, which are genetically determined serologically
detectable antigenic determinants. These allotypic deter-
minants are expressed on both the heavy and light chains
of IgG1, IgG2, and IgG3. The combination of individual
alleles is referred to as a haplotype [4] and GM haplotypes
vary among ethnic groups [5]. KM gene frequencies also
vary significantly among various ethnic groups. However,
the deployment of GM/KM allotyping for human popula-
tion genetic analysis, mapping global haplotype distribu-
tions, indicated that selection on GM haplotypes is low at
the human population level [6]. It has also been reported
that the levels of the IgG subclasses are influenced by the
GM allotypes in adult Caucasian blood donors [7] and in
African American populations [8].
The association of GM/KM allotypes with susceptibility to
several different diseases has been reported [9] and their
involvement in autoimmune disease has also been pro-
posed [10]. Some data have also indicated a possible asso-
ciation of GM/KM allotypes with malaria morbidity and
severity [11]. Differences between ethnic groups in the
distribution of GM/KM allotypes and a possible associa-
tion with malaria susceptibility were recently demon-
strated in a study carried out in eastern Sudan involving
comparison of groups of West African Fulani origin with
indigenous sympatric tribes [12]. At present, there is lim-
ited evidence for the involvement of human IgG allotypes
leading to functional differences in IgG antibodies as
compared to the evident differences seen between IgG
subclasses in malaria [2].
In the current study, a hypothesis suggesting that the GM/
KM make-up of individual immunoglobulin affects IgG
isotype levels, depending on target malaria antigen, was
examined. Consequently, the GM/KM allotypes might
influence the host susceptibility to malaria. Therefore, ten
GM (1, 2, 3, 5, 6, 13, 14, 17, 21, 23) and 2 KM (1, 3) allo-
types were investigated and combined with nine years of
longitudinal malaria incidence data collection. In addi-
tion, baseline antibody response to four leading asexual
blood-stage malaria vaccine-candidate antigens, compris-
ing the apical membrane antigen-1 (AMA-1), merozoite
surface protein-2 (MSP-2; 3D7 and FC27 alleles), and
Pf332-C231, was analysed to test this hypothesis. Results
revealed that, development of protective immunity is not
only attributed to repeated exposure with increasing age
[13], but also to genetic polymorphisms of the IgG in
terms of GM/KM phenotypes.
Methods
Study area
The study was carried out in Daraweesh village, eastern
Sudan, where malaria is hypoendemic with occasional
quite severe 'malaria seasons'. The malaria transmission
in the region is strictly seasonal but markedly unstable; in
'wet years' it peaks in October/November, after the sum-
mer rain, although a few sporadic cases also occur
between February and August. In Daraweesh, malaria
affects all age groups, although the incidence decreases
after twenty years of age. A detailed geographical, demo-
graphic and social description of the area has previously
been reported [14,15].
Study population
The inhabitants of Daraweesh are descendents of a
founder population of the West African Fulani-speaking
group, originally from Burkina Faso. The village founders
migrated to the Sudan more than hundred years ago
although the ethnic identity (and Fulani language) has
been maintained by frequent inter-marriage between
descendents of the small founding group and some mar-
riage with other Sudanese Fulani immigrants. In year
2000, the total population was approximately 500 inhab-
itants and during the 13-year study period, it ranged
between, 400 to 600 individuals. The plasma samples
used in this study were collected in the dry season in May
2005. All donors were malaria-free, no malaria parasite
was detected by microscopy or PCR in any of the blood
samples.
Longitudinal clinical and parasitological surveillances
From 1991 to 2004, the inhabitants of Daraweesh were
under regular clinical and parasitological malaria surveil-
lance [14,15]; except for four malaria seasons, where
funds were not available or follow-up was not complete.
Malaria was monitored by active and passive surveillances
by a research team over this period. The malaria was diag-
nosed if a patient had fever (oral temperature >37.5 °C),
or reported fever, and had microscopically-detectable par-
asitaemia after examination of a maximum of 200 fields
under oil immersion on each slide. Malaria patients were
treated with chloroquine or with pyrimethamine/sul-
phadoxine in case of chloroquine treatment failure or by
a combination of both as in year 2003 (therapeutic trial).
Notably, severe malaria incidence was extremely low dur-Malaria Journal 2009, 8:306 http://www.malariajournal.com/content/8/1/306
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ing the entire study period. Although prophylaxis was not
used, presumptive treatment was sometimes practiced.
Blood samples
Peripheral blood samples (3 ml) were collected from each
donor into a vacuum EDTA tube. After centrifugation the
plasma was collected into cryotubes and stored at -20°C
until used. The study had received ethical clearance from
the ethical committee at the Faculty of Medicine, Univer-
sity of Khartoum, and the Sudanese Federal Ministry of
Health. Consent was obtained from the village members
regarding the whole project and from the individual
donors, when blood samples were collected.
Measurement of total IgG and IgG isotypes by enzyme-
linked immunosorbent assay (ELISA)
An indirect enzyme-linked immunosorbent assay, ELISA,
[16] was used for measurement of total IgG and the sub-
classes; IgG1, IgG2, IgG3 and IgG4, against four asexual
blood-stage antigens; MSP2-3D7, MSP2-FC27, AMA-1
and Pf332-C231 [17]. Briefly, EIA/RIA plates (Costar, MA,
USA) were coated with AMA-1 at 1 μg/ml, 3D7 MSP 2 and
FC27 MSP 2 at 1 μg/ml, and Pf332-C231 at 5 μg/ml. The
AMA-1 protein, which has an N-terminal hexa-His tag,
was expressed in Escherichia coli and refolded in vitro. Both
the 3D7 and FC27 forms of MSP 2 were expressed in E. coli
with C-terminal hexa-His tags. The expression and purifi-
cation of these proteins will be described elsewhere (man-
uscript in preparation). The recombinant Pf332-C231
corresponds to a 231-amino acid fragment in the C-termi-
nal part of Pf332. The plates were incubated overnight at
4°C, and then blocked for 2 hrs with 0.5% bovine serum
albumin (BSA) diluted in carbonate buffer (pH 9.6).
Plasma samples diluted in incubation buffer (PBS + 0.5%
BSA), 1:1,000 (IgG) and 1:400 (IgG1-4), were added in
duplicate and incubated for 1 h at 37°C. The plates were
then washed four times, and bound IgG antibodies were
detected with goat anti-human IgG-ALP (1:2000)
(Mabtech, Nacka, Sweden). IgG subclasses were analysed
with their respective biotin conjugated mouse anti-
human subclass specific monoclonal antibodies: mouse
anti-human IgG1 1:1,000 (M15015, Clone NL16, SkyBio,
Bedfordshire, UK), mouse anti-human IgG2 1:3,000
(555874, Pharmingen, Erembodegem, Belgium), mouse
anti-human IgG3 1:1,000 (MH 1532, Caltag laboratories,
Paisley, UK) and mouse anti-human IgG4 1:2000 (B3648,
Sigma, St. Louis, USA). Alkaline phosphatase (ALP) con-
jugated streptavidin (Mabtech) diluted 1:2,000 was added
to detect bound antibodies of IgG2-4, while ALP-conju-
gated to goat anti-mouse Ig (Dakopatts, Glostrup, Den-
mark; 1:1,000) were used for IgG1 antibodies and the
plates were developed with nitrophenyl phosphate
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany).
The absorbance was read at 405 nm using a Vmax™
Kinetic microplate reader (Molecular devices, Menlo Park,
USA) and the antibody concentrations were deduced from
the log-log correlative coefficient of each IgG subclass
standard curve (six dilutions of myeloma proteins of
IgG1-4 subclasses), ranging from 0.01 to 3 μg/ml for
IgG1, 0.001 to 0.3 μg/ml for IgG2, 0.001 to 0.1 μg/ml for
IgG3 and 0.01 to 1 μg/ml for IgG4 according to the man-
ufacturer's recommendation (Biogenesis, Poole, Eng-
land). In plots, the antibody concentrations were
transformed into log 10 values without any changes in the
P - values obtained from the analysis of the raw values.
Determination of GM and KM allotypes
Allotyping of the serum samples from the above subjects
was carried out for G1M (1,2,3,17), G2M (23), G3M (5,6,
13,14,21), and KM (1,3) determinants by a standard hae-
magglutination-inhibition method [18]. Human erythro-
cytes (Group O Rh+) coated with anti-Rhesus antibodies
of known GM allotypes and mono-specific anti-allotype
sera were employed. Sera containing IgG of particular
allotype inhibit haemaggultination, but negative sera do
not.
Statistical analysis
Sigma Stat software was used for data analysis. There is
almost absolute linkage disequilibrium between individ-
ual GM alleles [19]; therefore, data were analysed as hap-
lotypes and also according to presence or absence of
individual markers. For comparisons of measurable
parameters e.g. age, levels of antibodies and etc, between
different categories grouped on basis of GM or KM allo-
typing, ANOVA or Kruskal-Wallis One Way Analysis of
Variance on Ranks was used. For pair wise analysis of the
same parameters between the same groups of donors, T-
test or Mann-Whitney Rank Sum Test was used.
Results
Frequency of GM and KM allotypes in Daraweesh
The individual GM allelic type (allotype) 5 and 17 were
detected in all (100%) donors involved in this study. The
vast majority of the donors had the GM 1 (99.5%) and
GM 14 (98.6%) alleles. The GM 13 (82.4%) allotype was
the next most frequent, while half of the population car-
ried the GM 6 allotype (49.5%). The other allotypes; 3, 21
and 23, were rare (Table 1). The donors were categorized
into five groups based on their GM phenotypes (combina-
tion of allotypes), four predominant phenotypes and a
fifth group which combines six minor groups taken
together and referred to as "others". Most of the donors
were carrying the four most frequent phenotypes; 1,17
5,13,14 (40.3%) and 1,17 5,13,14,6 (38.4%), followed
by 1,17 5,14 (9.3%) and 1,17 5,14,6 (6.9%), and the
"other" rare phenotypes were altogether accounting for
5.1%, (Table 2). The frequencies of the KM 1, 3, and 1,3
phenotypes were; 8.3%, 52.8% and 38.9%, respectively.
The age distribution of both GM and KM allotypes wereMalaria Journal 2009, 8:306 http://www.malariajournal.com/content/8/1/306
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comparable between all study groups. The majority
(65.7%) of the donors were females (Table 2).
Association of IgG allotypes with susceptibility to malaria
The average number of previous malaria episodes experi-
enced by each of the donors over nine years was used as
an index for differential susceptibility to malaria between
the GM or KM allotype groups. The GM 1,17 5,13,14,6
phenotype carriers experienced the highest number of
malaria episodes over the nine years of the follow up
(mean ± SD, 1.9 ± 1.5, range 0-7), followed by 1,17 5,14,6
(1.5 ± 1.6) and 1,17 5,13,14 (1.5 ± 1.3) phenotype carri-
ers, (Table 3). The lowest number of malaria episodes was
experienced by carriers of phenotype 1,17 5,14 (1.3 ± 1.5)
and the carriers of the minor allotypes (1.4 ± 1.6). Taken
all together, differences in the number of malaria episodes
between all GM phenotypes were not statistically detecta-
ble, P = 0.273, Kruskal-Wallis one way analysis of variance
on ranks.
However, grouping of the donors based on presence and
absence of certain set of GM allotypes (phenotypes),
showed that carriers of 1,17 5,13,14,6 phenotype as com-
pared to the non-carriers, had experienced statistically dis-
cernibly increased number of malaria episodes over the
years of the follow up (P = 0.037). The carriers of the other
three major GM phenotypes as compared with the non-
carriers of the corresponding phenotypes were equally
susceptible to malaria (Figure 1). To test whether an indi-
vidual allotype was associated with increased susceptibil-
ity, the analysis was repeated comparing the allotype 6
(1.8 ± 1.5, episodes) versus non-6 allotype (1.5 ± 1.4) car-
riers, P = 0.148; and allotype 13 (1.7 ± 1.4) versus non-13
allotype (1.3 ± 1.5) carriers, (P = 0.123). The other indi-
vidual allotypes were either present in almost all combi-
nations e.g. allotype 17, 5, and 1 and 14, or were very rare
e.g. allotypes 3, 21 and 23. However, the KM allotype car-
riers experienced a comparable number of malaria epi-
sodes during the longitudinal follow up, whether the
comparison was made between the three KM allotype car-
riers; 1, 3 and 1,3, together or in pairs (Table 3).
Total IgG and IgG isotype concentrations in relation to 
GM allotypes
The levels of the total IgG and IgG isotypes against the
four tested malaria antigens showed marked variation
between the isotypes, and also for the same isotype
between the antigens. For a specific IgG isotype, the con-
centration varies between individuals with different GM
allotypes, depending principally on the target antigen.
Comparing the carriers of specific phenotype with the
non-carriers of that phenotype was sometimes statistically
significant. The carriers of the 1,17 5,13 14,6 phenotype
had the highest frequency of high levels of IgG and IgG
isotypes in their sera, followed by the carriers of the 1,17
5,13,14 and 1,17 5, 14. However, there was no significant
difference between the carriers and non-carriers of the
1,17 5, 14,6 phenotype (Figure 2).
Total IgG and IgG isotype concentrations in relation to KM 
allotypes
The above comparisons of the IgG and its isotype concen-
trations to the four target antigens between allotypes car-
riers were repeated, but using KM (1, 3, and 1,3) instead
of GM allotypes. Results showed that there was less influ-
ence of the KM allotype on the total IgG and IgG isotypes
concentration, regardless of the target antigen. The only
significant differences were the higher concentration of
total IgG to MSP2-FC27 and to Pf332-C231 antigens in
the plasma obtained from the KM 3 compared to that
obtained from the KM 1,3 phenotype carriers (Figure 3).
Discussion
In malaria hyper-endemic settings, protection from
malaria mortality and morbidity is achieved with age as a
Table 1: The frequency of the individual GM allotypes of IgG 
immunoglobulin in Daraweesh village.
GM allotypes Proportions (number of individuals)
5 100% (216)
17 100% (216)
1 99.5% (215)
14 98.6% (213)
13 82.4% (178)
6 49.5% (107)
3 1.9% (4)
21 1.4% (3)
23 0.5% (1)
Table 2: The frequency of the GM phenotypes (upper rows) and 
KM allotypes (bottom rows) of IgG immunoglobulin in 
Daraweesh village. 
GM/KM Phenotypes Frequency Age (years) Sex (F/M)
GM Mean ± SD
1,17 5,14 9.3% (20) 20.2 ± 8.341 18/2
1,17 5,14,6 6.9% (15) 22.9 ± 16.1 8/7
1,17 5,13,14 40.3% (87) 26.2 ± 17.8 61/26
1,17 5,13,14,6 38.4% (83) 26.8 ± 17.0 48/35
Others [n, 6] 5.1% (11) 22.9 ± 16.9 7/4
P = 0.324
KM
1 8.3% (18) 23.4 ± 13.1 15/3
3 52.8% (114) 24.9 ± 17.2 67/47
1,3 38.9% (84) 26.8 ± 18.4 60/24
Kruskal-Wallis P = 0.872
Total 216 142/74
The age and sex of the donors are shown.
The others are: 1,17 5,6 = 3; 17 5,13,14 = 1; 1,3,17 5,13,14 = 1; 1,3,17 
5,13,14,6 = 2; 1,17 5,13,14,6,21 = 3; 1,3,17 23 5,13,14,6 = 1Malaria Journal 2009, 8:306 http://www.malariajournal.com/content/8/1/306
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consequence of immunity and this protection is aug-
mented in subpopulations by inherent, genetically con-
trolled host factors. The genetic factors involved in
resistance to malaria are clearly numerous, the best
known involving various balanced polymorphisms in
haemoglobin genes. In this study, the number of malaria
episodes over nine years of clinical and parasitological fol-
low-up was recorded for a cohort of around half of the
Daraweesh village inhabitants. The data showed who was
most susceptible/resistant to malaria infection. Integra-
tion of this data together with genotyping of GM/KM allo-
types and measurement of total IgG and IgG isotypes to
four malaria antigens revealed interesting findings. The
study showed that, the GM allelic combinations but not
the KM allelic combinations had significant influence in
uncomplicated malaria susceptibly and in the type and
concentration of IgG isotype. While the implication of
GM allotypes in susceptibility to bacterial infections and
other diseases have been known for some time [20,21],
the role of GM/KM polymorphisms in malaria suscepti-
bility has only recently been investigated [12,22]. In this
study, the GM 1,17 5,13,14,6 phenotype was significantly
associated with increased susceptibility to malaria infec-
tions although paradoxically it was significantly associ-
ated with the highest baseline concentration of certain
IgG and IgG isotypes. Both associations were age inde-
pendent, and the latter one was largely dependent on the
target antigen.
GM allotypes have been assessed in all villagers tested and
the frequencies of each GM or KM allotype determined.
Nearly all villagers have GM allotypes 5, 17, 1 and 14 in
their GM phenotype. This leaves allotypes 13 and 6 as the
major GM allotype differences between villagers, both of
which are located within the G3 constant region. Allo-
types 1 and 17 are believed to be located in the G1 con-
stant region, and do not, therefore, differ in 215 of the 216
villagers. The fact that the GM differences in this cohort
are almost entirely in the G3 constant region and the sig-
nificance of the GM polymorphisms in terms of possible
differences in antibody functionality between the suscep-
tible (i.e. 13, 6 containing allotypes) and the less suscep-
tible (i.e. phenotypes not containing 13, 6 allotypes),
worth further investigation. In this study, the GM 1,17
5,14 carriers, compared with the carriers of the other phe-
notypes or the non-carriers of 1,17 5,14 phenotype, had
experienced the least number of malaria episodes
although the differences were not significant. The signifi-
cantly raised antibodies in the plasma of the carriers of the
GM 1,17 5,13,14,6 phenotype, were mainly the total IgG
and IgG2, but not the IgG3 isotype. The levels of IgG4 iso-
type to all antigens were generally very low, not associated
with age and apparently were not increased after acute
infection (unpublished data). The allotype-specific varia-
tion in the levels of IgG subclasses was antigen-depend-
ent. This finding is supporting and adding to a previous
report suggesting inherent ability of individual malaria
antigens in antibody class switching [23].
The GM 1,17 5,13,14,6 phenotype was the second most
prevalent phenotype in the area. This same phenotype
was found to be more dominant in the Massalit, a tribe
presumed to be more susceptible to malaria than Fulani
[12]. The above-mentioned implication of GM 1,17
5,13,14,6 phenotype, might be due to the GM 6 allotype
component. The allotype 6 was detected in half of the
Daraweesh inhabitants, while at a global level the GM
phenotypes containing GM 6 was recognized only in Afri-
cans, but not in other populations [6]. Recently, it was
shown that, there was an inverse relationship between car-
riage of GM 1,17 5,13,14,6 phenotype and occurrence of
uncomplicated malaria in Benin [22]. That observation
Table 3: The mean number and range of previous malaria episodes experienced by donors with different GM/KM allotypes/
phenotypes, over 9-years of follow up in Daraweesh
Donors grouping Number of malaria episodes P-values
Mean ± SD Range
GM allotypes
1,17 5,14 1.3 ± 1.5 0 - 5 P = 0.273
Kruskal-Wallis One Way Analysis of Variance on Ranks
1,17 5,14,6 1.5 ± 1.6 0 - 5
1,17 5,13,14 1.5 ± 1.3 0 - 4
1,17 5,13,14,6 1.9 ± 1.5 0 - 7
KM allotypes
1 (18) 1.7 ± 1.2 0 - 3 P = 0.342
Kruskal-Wallis
3 (114) 1.7 ± 1.5 0 - 7
1,3 (84) 1.5 ± 1.4 0 - 6Malaria Journal 2009, 8:306 http://www.malariajournal.com/content/8/1/306
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The figure shows the average number of malaria episodes experienced by the carriers of the major GM phenotypes; 1,17 5,14  (a) - 1,17 5,14,6 (b) - 1,17 5,13,14 (c) - 1,17 5,13,14,6 (d), during nine years of follow up in Daraweesh village Figure 1
The figure shows the average number of malaria episodes experienced by the carriers of the major GM pheno-
types; 1,17 5,14 (a) - 1,17 5,14,6 (b) - 1,17 5,13,14 (c) - 1,17 5,13,14,6 (d), during nine years of follow up in 
Daraweesh village. Comparing the carriers versus non-carrier of each of the 4 phenotypes, the only significant difference 
was that of 1,17 5,13,14,6 (d). The box represents 25-75 percentile, the horizontal line is the median value vertical bar is 95 
percentile and open circle are the outliers
Figure 1. 
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Concentrations (log 10) of total IgG and IgG isotypes to four antigens: MSP2-3D7, AMA-1, Pf332-C231 and MSP2-FC27 Figure 2
Concentrations (log 10) of total IgG and IgG isotypes to four antigens: MSP2-3D7, AMA-1, Pf332-C231 and 
MSP2-FC27. The figure demonstrates the significant differences in levels of the above antibodies between the each of the GM 
phenotype carriers; 1,17 5,14 - 1,17 5,14,6 - 1,17 5,13,14 - 1,17 5,13,14,6, and the corresponding-phenotype non-carriers.
 Figure 2 A. 
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does not contradict this study findings, as in their study all
individuals involved in the study were infected with
malaria and there were small in age (less than 10 years).
Furthermore, in the Benin study, the clinical grouping was
based on a single observation, also, the immune profile of
the patients was not known. In this study, the above lim-
itations were surmounted. In addition, the diversity that
could result from the differences due to ethnicity was
overcome by having a single homogenous ethnic study
group. The KM allotypes were not statistically associated
with malaria susceptibility.
The influence of GM/KM allotypes on antibody response
is assumed to be due to alteration of antibody specificity
through variable regions [24] or by modification of anti-
body constant region [25]. The data showed limited
effects for the GM/KM phenotypes on the concentration
of IgG isotypes. However, there was a tendency for an
antigen-dependent pattern of responses. Having exam-
ined five (IgG and subclasses) antibody titres to four anti-
gens in the same individual, lack of consistency in levels
of any subclass to all examined antigens in any of the GM/
KM phenotypes carrier groups, was an evidence for lack of
an innate effect for allotypes in levels of subclasses with-
out the influence of the antigens. The antigen-dependent
IgGs responses in malaria, are shown to have opposing
significances i.e. exposure or protection, in a recent study
from Kenya [26].
Recently, it has also been found that, there is a higher
prevalence than previously expected, of primary partial
immune deficiencies including IgG isotypes and GM allo-
types, in apparently healthy individuals [27]. Finally, the
influence of GM allotypes (immunoglobulin C-region) in
immunity is conventionally thought to be associated with
the V-region, as a particular allotype might be in linkage
disequilibrium with a particular V- region determinant
[28]. Alternatively, GM6 and GM13 allotypes, in this
study, could contribute to formation of idiotypes associ-
ated with lower immunological responsiveness. On the
other hand, the C-region (namely CH2 and CH3
domains) could modify the immunity through its affinity
to the FcγR, and there might be certain GM allotype inter-
action with particular FcγR variant leading to either
increased or decreased immune response [28]. A work
showing the association between GM allotypes and FcγR
polymorphisms and another showing the association
between the levels of total IgG and IgG subclasses to dif-
ferent antigens and protection from malaria in the same
cohort, are in progress.
Conclusion
This study shows that, the GM allotypes are involved in
susceptibility to uncomplicated malaria. Furthermore,
there are indications for involvement of GM and to a
Concentrations (log 10) of total IgG and IgG isotypes to two  antigens: Pf332-C231 and MSP2-FC27 Figure 3
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to two antigens: Pf332-C231 and MSP2-FC27. The fig-
ure demonstrates the significant differences in levels of the 
above antibodies between the each of the KM 1, 1,3 and 3 
allotype carriers. The box represents 25-75 percentile, the 
horizontal line is the median value vertical bar is 95 percen-
tile and open circle are the outliers. Only comparisons of sta-
tistically significant differences are presented
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lesser extent of KM allotypes in control of total IgG and
IgG isotype concentrations, depending on target malaria
antigen. The GM 1,17 5,13,14,6 phenotype was associated
with higher baseline levels of total IgG and non-cytophilic
IgG2. While GM 1,17 5,14 phenotype was associated with
least susceptibility and highest baseline IgG3 response.
Finally, the allotype GM 6, which is believed to be absent
in Europeans was detected in 50% of the study population
(Fulani).
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
HG, DA and TT planed, established, maintained and sup-
ported the Daraweesh nine-years clinical and parasitolog-
ical data; HG, AN and GE supervised and collected the
field samples; AR, NI, MTB, KB, GH and JP were responsi-
ble for the laboratory data, HG, DA, TT, MTB, KB, JP and
GH, were responsible for the study design, data analysis,
results interpretation and paper drafting, all authors con-
tributed to manuscript writing
Acknowledgements
We would like to thank all the inhabitants of Daraweesh in eastern Sudan, 
our field research teams, all researchers and students who established and 
involved in this project and the previous local health authorities who sup-
ported the project over the years. Professor Robin Anders is acknowl-
edged for the supply of AMA-1, MSP-2 FC27 and 3D7 antigens while Halima 
Balogun prepared the recombinant Pf332-C231 antigen. The Daraweesh 
Project is built on several short and long term projects received funds from 
several donors principally DANIDA and TDR/WHO from 1990 to 2004. 
Riad Bayoumi, Thor Theander, Lars Hviid, David Arnot and Gwiria Satti, 
were the principal founders of the project. MTB and KB were supported by 
grants from the Swedish Agency for Research Development with Develop-
ing Countries (SIDA/SAREC), the Swedish Medical Research Council (VR) 
as well as grants within the BioMalPar European Network of Excellence 
(LSMP-CT-2004-503578), from the Priority I "Life Sciences, Genomics and 
Biotechnology of Health" in the 6th Framework Programme
References
1. Kwiatkowski DP: How malaria has affected the human
genome and what human genetics can teach us about
malaria.  Am J Hum Genet 2005, 77:171-192.
2. Groux H, Gysin J: Opsonization as an effector mechanism in
human protection against asexual blood stages of Plasmo-
dium falciparum: functional role of IgG subclasses.  Res Immunol
1990, 141:529-542.
3. Roussilhon C, Oeuvray C, MÜller-Graf C, Tall A, Rogier C, Trape JF,
Theisen M, Balde A, Pérignon JL, Druilhe P: Long-term clinical pro-
tection from falciparum malaria is strongly associated with
IgG3 antibodies to merozoite surface protein 3.  PLoS Med
2007, 13:e320.
4. Lefranc MP, Giudicelli V, Kaas Q, Duprat E, Jabado-Michaloud J, Scav-
iner D, Ginestoux C, Clément O, Chaume D, Lefranc G: IMGT, the
international ImMunoGeneTics information system.  Nucleic
Acids Res 2005:D593-7.
5. Lefranc MP, Lefranc G: Molecular genetics of immunoglobulin allotype
expression. In The human IgG subclasses: Molecular analysis of structure
function and regulation Farouk Shakib Oxford; 1990:43-78. 
6. Dugoujon JM, Hazout S, Loirat F, Mourrieras B, Crouau-Roy B,
Sanchez-Mazas A: GM haplotype diversity of 82 populations
over the world suggests a centrifugal model of human migra-
tions.  Am J Phys Anthropol 2004, 125:175-192.
7. Pandey JP, French MA: GM phenotypes influence the concentra-
tions of the four subclasses of immunoglobulin G in normal
human serum.  Hum Immunol 1996, 51:99-102.
8. Pandey JP, Gunsolley JC, Tew JG, Schenkein HA: GM allotypes and
IgG subclass concentrations in blacks.  Exp Clin Immunogenet
1996, 13:126-130.
9. Whittingham S, Propert DN: Gm and Km allotypes, immune
response and disease susceptibility.  Monogr Allergy 1986,
19:52-70.
10. Dugoujon JM, Cambon-Thomsen A: Immunoglobulin allotypes
(GM and KM) and their interactions with HLA antigens in
autoimmune diseases.  Autoimmunity 1995, 22:245-260.
11. Facer CA: Direct antiglobulin reactions in Gambian children
with P. falciparum malaria. III. Expression of IgG subclass
determinants and genetic markers and association with
anaemia.  Clin Exp Immunol 1980, 41:81-90.
12. Pandey JP, Nasr A, Rocca KM, Troy-Blomberg M, Elghazali G: Signif-
icant differences in GM allotype frequencies between two
sympatric tribes with markedly differential susceptibility to
malaria.  Parasite Immunol 2007, 29:267-269.
13. Baird JK: Host age as a determinant of naturally acquired
immunity to Plasmodium falciparum.  Parasitol Today 1995,
11:105-111.
14. Giha HA, Rosthoj S, Dodoo D, Hviid L, Satti GM, Scheike T, Arnot
DE, Theander TG: The epidemiology of febrile malaria epi-
sodes in an area of unstable and seasonal transmission.  Trans
R Soc Trop Med Hyg 2000, 94:645-651.
15. Creasey A, Giha H, Hamad AA, ElHassan IM, Theander TG, Arnot
DE: Eleven years of malaria surveillance in a Sudanese village
highlights unexpected variation in individual disease suscep-
tibility and outbreak severity.  Parasitology 2004, 129:263-271.
16. Perlmann H, Perlmann P, Berzins K, Wahlin B, Troye-Blomberg M,
Hagstedt M, Andersson I, HÖgh B, Petersen E, BjÖrkman A: Dissec-
tion of the human antibody response to the malaria antigen
Pf155/RESA into epitope specific components.  Immunol Rev
1989, 112:115-132.
17. Nasr A, Iriemenam NC, Troye-Blomberg M, Giha HA, Balogun HA,
Osman OF, Montgomery SM, ElGhazali G, Berzins K: Fc gamma
receptor IIa (CD32) polymorphism and antibody responses
to asexual blood-stage antigens of Plasmodium falciparum
malaria in Sudanese patients.  Scand J Immunol 2007, 66:87-96.
18. Field LL, Dugoujon JM: Immunoglobulin allotyping (Gm, Km) of
GAW5 families.  Genet Epidemiol 1989, 6:31-33.
19. Steinberg AG, Cook CE: The distribution of human immunoglobulin allo-
types Oxford University Press, New York, NY; 1981. 
20. Ambrosino DM, Schiffman G, Gotschlich EC, Schur PH, Rosenberg
GA, DeLange GG, van Loghem E, Siber GR: Correlation between
G2m(n) immunoglobulin allotype and human antibody
response and susceptibility to polyasaccharide encapsulated
bacteria.  J Clin Invest 1985, 75:1935-1942.
21. Granoff DM, Boies E, Squires J, Pandey JP, Suarez B, Oldfather J,
Rodey GE: Interactive effect of genes associated with immu-
noglobulin allotypes and HLA specificities on susceptibility
to  Haemophilus influenzae disease.  J Immunogenet 1984,
11:181-188.
22. Migot-Nabias F, Noukpo JM, Guitard E, Doritchamou J, Garcia A,
Dugoujon JM: Imbalanced distribution of GM immunoglobulin
allotypes according to the clinical presentation of Plasmo-
dium falciparum malaria in Beninese children.  J Infect Dis 2008,
198:1892-1895.
23. Tongren JE, Drakeley CJ, McDonald SL, Reyburn HG, Manjurano A,
Nkya WM, Lemnge MM, Gowda CD, Todd JE, Corran PH, Riley EM:
Target antigen age, and duration of antigen exposure inde-
pendently regulate immunoglobulin G subclass switching in
malaria.  Infect Immun 2006, 74:257-264.
24. Moxley G, Gibbs RS: Polymerase chain reaction-based geno-
typing for allotypic markers of immunoglobulin kappa shows
allelic association of Km with kappa variable segment.
Genomics 1992, 13:104-108.
25. Cooper LJ, Shikhman AR, Glass DD, Kangisser D, Cunningham MW,
Greenspan NS: Role of heavy chain constant domains in anti-
body-antigen interaction. Apparent specificity differences
among streptococcal IgG antibodies expressing identical
variable domains.  J Immunol 1993, 150:2231-2242.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Malaria Journal 2009, 8:306 http://www.malariajournal.com/content/8/1/306
Page 10 of 10
(page number not for citation purposes)
26. Osier FH, Fegan G, Polley SD, Murungi L, Verra F, Tetteh KK, Lowe
B. Mwangi T, Bull PC, Thomas AW, Cavanagh DR, McBride JS, Lanar
DE, Mackinnon MJ, Conway DJ, Marsh K: Breadth and magnitude
of antibody responses to multiple Plasmodium falciparum
merozoite antigens are associated with protection from clin-
ical malaria.  Infect Immun 2008, 76:2240-2248.
27. Bossuyt X, Moens L, Van Hoeyveld E, Jeurissen A, Bogaert G, Sauer
K, Proesmans M, Raes M, De Boeck K: Coexistence of (partial)
immune defects and risk of recurrent respiratory infections.
Clin Chem 2007, 53:124-130.
28. Redpath S, Michaelsen TE, Sandlie I, Clark MR: The influence of the
hinge region length in binding of human IgG to human
Fcgamma receptors.  Hum Immunol 1998:59-720.